Published in Immunome Res on October 29, 2007
Hydrolyzing proficiency of keratinases in feather degradation. Indian J Microbiol (2014) 0.79
Improving peptide-MHC class I binding prediction for unbalanced datasets. BMC Bioinformatics (2008) 0.76
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Profile hidden Markov models. Bioinformatics (1998) 56.04
Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science (1992) 4.74
The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol (1995) 4.60
Protein volume in solution. Prog Biophys Mol Biol (1972) 4.00
Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science (1992) 3.64
AAindex: Amino Acid Index Database. Nucleic Acids Res (1999) 3.52
The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell (1993) 3.44
Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature (1992) 3.12
The characterization of amino acid sequences in proteins by statistical methods. J Theor Biol (1968) 2.75
Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. Proc Natl Acad Sci U S A (1992) 2.16
MHCPEP, a database of MHC-binding peptides: update 1997. Nucleic Acids Res (1998) 2.02
Identifiying human MHC supertypes using bioinformatic methods. J Immunol (2004) 1.72
Analysis of peptide-protein binding using amino acid descriptors: prediction and experimental verification for human histocompatibility complex HLA-A0201. J Med Chem (2005) 1.62
Methods for prediction of peptide binding to MHC molecules: a comparative study. Mol Med (2002) 1.61
Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc Natl Acad Sci U S A (1995) 1.59
PROFEAT: a web server for computing structural and physicochemical features of proteins and peptides from amino acid sequence. Nucleic Acids Res (2006) 1.47
Macromolecular bioactivity: is it resonant interaction between macromolecules?--Theory and applications. IEEE Trans Biomed Eng (1994) 1.39
XRCC1 is phosphorylated by DNA-dependent protein kinase in response to DNA damage. Nucleic Acids Res (2006) 1.32
Structural principles that govern the peptide-binding motifs of class I MHC molecules. J Mol Biol (1998) 1.20
Prediction of MHC-binding peptides of flexible lengths from sequence-derived structural and physicochemical properties. Mol Immunol (2006) 1.11
Modeling the structure of bound peptide ligands to major histocompatibility complex. Protein Sci (2004) 1.11
Is it possible to analyze DNA and protein sequences by the methods of digital signal processing? IEEE Trans Biomed Eng (1985) 1.09
Towards in silico prediction of immunogenic epitopes. Trends Immunol (2003) 1.02
MHC-BPS: MHC-binder prediction server for identifying peptides of flexible lengths from sequence-derived physicochemical properties. Immunogenetics (2006) 1.02
Free energy mapping of class I MHC molecules and structural determination of bound peptides. Protein Sci (1996) 0.99
Epitope prediction algorithms for peptide-based vaccine design. Proc IEEE Comput Soc Bioinform Conf (2003) 0.89
Computational determination of side chain specificity for pockets in class I MHC molecules. Mol Immunol (1996) 0.84
Prediction of genomewide conserved epitope profiles of HIV-1: classifier choice and peptide representation. Stat Appl Genet Mol Biol (2005) 0.83
Toward the quantitative prediction of T-cell epitopes: QSAR studies on peptides having affinity with the class I MHC molecular HLA-A*0201. J Comput Biol (2004) 0.81
Prediction of T-cell epitopes based on least squares support vector machines and amino acid properties. Anal Chim Acta (2006) 0.79
Peptide reagent design based on physical and chemical properties of amino acid residues. J Comput Chem (2007) 0.79
Genomewide conserved epitope profiles of HIV-1 predicted by biophysical properties of MHC binding peptides. J Comput Biol (2004) 0.78
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature (2013) 5.35
Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. Immunity (2013) 4.82
Advantage of rare HLA supertype in HIV disease progression. Nat Med (2003) 4.08
Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. J Virol (2011) 4.06
B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Nat Biotechnol (2012) 3.69
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci U S A (2011) 3.51
Identifying differential expression in multiple SAGE libraries: an overdispersed log-linear model approach. BMC Bioinformatics (2005) 3.12
Statistical mixture modeling for cell subtype identification in flow cytometry. Cytometry A (2008) 3.06
Pathway level analysis of gene expression using singular value decomposition. BMC Bioinformatics (2005) 2.78
High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J Virol Methods (2009) 2.75
SoDA: implementation of a 3D alignment algorithm for inference of antigen receptor recombinations. Bioinformatics (2005) 2.41
Diversification of Ig superfamily genes in an invertebrate. Science (2004) 2.25
The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling. Nat Immunol (2010) 2.20
H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination. PLoS One (2011) 2.02
Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting. PLoS One (2011) 1.99
Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated. J Exp Med (2011) 1.97
Microbial colonization influences early B-lineage development in the gut lamina propria. Nature (2013) 1.96
Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design. J Virol (2012) 1.86
Invertebrate immune systems--not homogeneous, not simple, not well understood. Immunol Rev (2004) 1.72
Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies. PLoS Pathog (2011) 1.70
Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody. Proc Natl Acad Sci U S A (2012) 1.70
Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies. J Exp Med (2013) 1.68
Spatial Mixture Modelling for Unobserved Point Processes: Examples in Immunofluorescence Histology. Bayesian Anal (2009) 1.58
SoDA2: a Hidden Markov Model approach for identification of immunoglobulin rearrangements. Bioinformatics (2010) 1.57
Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Blood (2007) 1.49
Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation. J Virol (2011) 1.32
Identification and utilization of arbitrary correlations in models of recombination signal sequences. Genome Biol (2002) 1.29
Application of cDNA microarray technology to in vitro toxicology and the selection of genes for a real-time RT-PCR-based screen for oxidative stress in Hep-G2 cells. Toxicol Pathol (2002) 1.27
Measurement of cell migration on surface-bound fibronectin gradients. Langmuir (2004) 1.21
First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis. PLoS One (2010) 1.20
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1. J Clin Invest (2014) 1.19
Flow: Statistics, visualization and informatics for flow cytometry. Source Code Biol Med (2008) 1.17
A two-tiered model for simulating the ecological and evolutionary dynamics of rapidly evolving viruses, with an application to influenza. J R Soc Interface (2010) 1.13
Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice. J Immunol (2010) 1.07
Prospective estimation of recombination signal efficiency and identification of functional cryptic signals in the genome by statistical modeling. J Exp Med (2003) 1.06
Selective and site-specific mobilization of dermal dendritic cells and Langerhans cells by Th1- and Th2-polarizing adjuvants. Proc Natl Acad Sci U S A (2010) 1.06
Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious. J Virol (2004) 1.05
Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors. Proc Natl Acad Sci U S A (2013) 1.05
Comparison of multiple vaccine vectors in a single heterologous prime-boost trial. Vaccine (2008) 1.03
Large-scale analysis of human heavy chain V(D)J recombination patterns. Immunome Res (2008) 1.00
Patient socioeconomic status is an independent predictor of operative mortality. Ann Surg (2010) 0.98
Secretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage. Cell Immunol (2010) 0.95
The Multiscale Systems Immunology project: software for cell-based immunological simulation. Source Code Biol Med (2008) 0.93
beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct. J Immunol (2009) 0.93
Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol (2006) 0.92
SpA: web-accessible spectratype analysis: data management, statistical analysis and visualization. Bioinformatics (2005) 0.91
Longitudinal analysis of T-cell receptor variable beta chain repertoire in patients with acute graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2006) 0.90
Quantification of total T-cell receptor diversity by flow cytometry and spectratyping. BMC Immunol (2013) 0.88
The dynamics of T-cell receptor repertoire diversity following thymus transplantation for DiGeorge anomaly. PLoS Comput Biol (2009) 0.87
Key mutations stabilize antigen-binding conformation during affinity maturation of a broadly neutralizing influenza antibody lineage. Proteins (2015) 0.86
A Bayesian approach for estimating calibration curves and unknown concentrations in immunoassays. Bioinformatics (2010) 0.84
Neonate-primed CD8+ memory cells rival adult-primed memory cells in antigen-driven expansion and anti-viral protection. Int Immunol (2006) 0.83
Rescue of cytotoxic function in the CD8alpha knockout mouse by removal of MHC class II. Eur J Immunol (2008) 0.80
A model for migratory B cell oscillations from receptor down-regulation induced by external chemokine fields. Bull Math Biol (2013) 0.79
Paradoxical suppression of poly-specific broadly neutralizing antibodies in the presence of strain-specific neutralizing antibodies following HIV infection. J Theor Biol (2011) 0.78
Terminal deoxynucleotidyl transferases from elasmobranchs reveal structural conservation within vertebrates. Immunogenetics (2003) 0.78
An information-theoretic method for the treatment of plural ancestry in phylogenetics. Mol Biol Evol (2008) 0.77
Genetic correlates of autoreactivity and autoreactive potential in human Ig heavy chains. Immunome Res (2009) 0.76
Improving peptide-MHC class I binding prediction for unbalanced datasets. BMC Bioinformatics (2008) 0.76
Mixtures of Gaussian Wells: Theory, Computation, and Application. Comput Stat Data Anal (2012) 0.75
Computational immunology--from bench to virtual reality. Ann Acad Med Singapore (2007) 0.75